We are located in Paris
At MedInsights, we are dedicated to bringing optimized therapeutic options for patients suffering from rare diseases.
Our internal drug repositioning engine, NexusRx, serves as a cornerstone for our discovery research, employing internal sets of proprietary algorithms to detect unknown and unforeseen relationships between disease-targets-drugs. This opens up preclinical validation opportunities which we perform in close partnerships with our academic collaborators. We envision to perform clinical trials and bring therapeutics from lab to bed side.
-
Unified data umbrella: Seamlessly generate insights from over 25+ sources, including clinical trials, publications, omics datasets, patents, anonymized patient datasets (proprietary) and other specialized databases (internal and external).
-
Navigating the Disease Landscape: Generate comprehensive network models that visualize disease progression and drug interactions at the molecular level.
-
Exploring Hidden Connections: Find correspondence between networks to to identify promising drug-disease matches that might have been missed.
-
Expansion of Treatment Options: Uncover novel uses for existing medications based on their interaction with disease pathways and pharmacological actions.
-
Accelerate Drug Development: Pinpoint promising drug leads with high potential for further development.
-
Optimize Clinical Trials: Clinical endpoint mapping and adverse events mapping facilitates identification of potential biomarkers that can streamline drug development by analyzing previous treatment response in patients.
Introducing Our Fully-Integrated Drug Discovery Framework
NEXUS-Rx
How NEXUS-Rx works?
Accelerate drug discovery by illuminating complex disease landscapes and uncovering hidden therapeutic opportunities within vast data types
OUR CLIENT PORTFOLIO